← Back to headlines
Morgan Stanley Raises Vertex Pharmaceuticals Price Target to $612
Morgan Stanley has increased its price target for Vertex Pharmaceuticals to $612 from $596, indicating a positive outlook for the company's stock.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Oil Traffic Through Danish Straits Reaches Historic Highs, Raising Safety and Pollution Concerns
11m ago
Poland Increases Subsidies for Employees with Disabilities in 2026
24m ago